Tizanidine is effective in the treatment of myofascial pain syndrome

Pain Physician

Volumn 5, Issue 4, 2002, Pages 422-432

  Malanga, Gerard A ^a   Gwyn, Matthews W ^a   Smith, Rachael ^a   Miller, Dorothy ^a  

^a NONE

Author keywords

Adrenergic; Myofascial pain syndrome; Tizanidine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ASPARTATE AMINOTRANSFERASE; PARACETAMOL; TIZANIDINE;

ADULT; ANALGESIA; ARTICLE; BACKACHE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; INFECTION; MEDICAL ASSESSMENT; MUSCULOSKELETAL DISEASE; MYALGIA; MYOFASCIAL PAIN; NEUROLOGIC DISEASE; PAIN ASSESSMENT; PHYSICAL DISABILITY; QUESTIONNAIRE; RASH; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SLEEP; SOMNOLENCE; SPASTICITY; TITRIMETRY; TREATMENT OUTCOME; VERTIGO; VISUAL ANALOG SCALE;

EID: 0036816035     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Blasberg B, Chalmers A. Temporomandibular pain and dysfunction syndrome associated with generalized musculoskeletal pain: A retrospective study. J Rheumatol 1989; 16:87-90.
2. Skootsky SA, Jaeger B, Dye RK. Prevalence of myofascial pain in general internal medicine practice. West J Med 1989;151:157-160.
3. Goldenberg DL. Fibromyalgia, chronic fatigue syndrome and myofascial pain syndrome. Curr Opin Rheum 1991;3:247-258.
4. Travell JG, Simons DG (eds.). Myofascial pain and dysfunction: The trigger point manual. Baltimore, Williams & Wilkins, Co., Baltimore, 1983, pp 103-164.
5. Dao TT, Lund JP, Remillard G, Lavigne GJ. Is myofascial pain of the temporal muscles relieved by oral sumitriptan? A cross-over pilot study. Pain 62:241-244.
6. Edwards RHT. Hypothesis of peripheral and central mechanisms underlying occupational muscle pain and injury. Eur J Appl Physiol 1988; 57:275-281.
7. Delwaide PJ, Pennisi G. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity. Neurology 1994; 44:S21-S27.
8. Mojica JAP, Mancao BD, Perez MLP et al. A dose-finding therapeutic trial on tizanidine in Filipinos with acute muscle spasm. Philipp J Intern Med 1994; 32:141-145.
9. Hutchinson DR, Daniels F. A multinational study in general practice to evaluate the effectiveness and tolerability of tizanidine in the treatment of painful muscle spasms. Br J Clin Res 1990; 1:39-48.
10. Fischer AA. Pressure threshold meter: Its use for quantification of tender spots. Arch Phys Med Rehabil 1986;67:836-838.
11. Fischer AA. Pressure algometry over normal muscles. Standards values, validity and reproducibility of pressure threshold. Pain 1987;30:115-126.
12. Nadler SF, Feinberg JH, Reisman S et al. Effect of topical heat on electromyographic power density spectrum in subjects with myofascial pain and normal controls: A pilot study. Am J Phys Med Rehabil 2001; 80:809-815.
13. Perotto AO. Anatomical guide for the electromyographer (3rd edition). Illinois, Charles C. Thomas Publisher, Illinois, 1994, pp 250-251.
14. Houtchens MK, Richert JR, Sami A et al. Open Label gabapentin treatment for pain in multiple sclerosis. Mult Scler 1997; 3:250-253.
15. Bennett RM. Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999; 74:385-398.
16. Davies J, Johnston SE, Hill DR et al. Tizanidine (DS 103-282), a centrally acting muscle relaxant, selectively depresses excitation of feline dorsal horn neurons to noxious stimuli by an action at alpha 2 adrenoreceptors. Neurosci Lett 1984; 48:197-202.
17. Yanagisawa N, Tanaka R, Ito Z. Reciprocal Ia inhibition in spastic hemiplegia of man. Brain 1976; 99:555-574.
18. Koyuncuoglu H, Kara I, Gunel MA et al. N-methyl-D-aspartate antagonists, glutamate release inhibitors, 4-aminopyridine at neuromuscular transmission. Pharmacol Res 1998; 6:485-491.
19. Moon DE, Lee DH, Han HC et al. Adrenergic sensitivity of the sensory receptors modulating mechanical allodynia in a rat neuropathic pain model. Pain 1999; 80:589-595.
20. Bendtsen L, Jensen R. AmitryptylineAmitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalagia 2000; 20:603-610.
21. Dao TT, Lund JP, Remillard G et al. Is myofascial pain of the temporal muscles relieved by oral sumitriptansumatriptan? A cross-over pilot study. Pain 1995; 62:241-244.
22. Frost A. Diclofenac versus lidocaine as injection therapy in myofascial pain. Scand J Rheumatol 1986; 15:153-156.
23. Mathias BJ, Dillingham TR, Zeigler DN et al. Topical capsaicin for chronic neck pain; a pilot study. Am J Phys Med Rehabil 1995; 71:39-44.
24. Griffin MR. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury. Am J Med 1998; 104:23-29.
25. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999; 106:13-24.
26. Zanaflex® Package Insert. Physicians Desk Reference 2001. Montvale, NJ, Medical Economics Company, Inc., New Jersey, 2001, pp 670-672.